Form 4: Strata Critical Medical Insider Sells Shares

William A. Heyburn, Co-CEO and CFO of Strata Critical Medical, Inc., reported a transaction involving the sale of 31,671 shares of Class A common stock.

Summary

• William A. Heyburn, who holds the positions of Director, Co-CEO, and CFO at Strata Critical Medical, Inc., has reported a transaction on June 8, 2026.
• This transaction involved the disposition of 31,671 shares of Class A common stock.
• The shares were withheld by the Issuer to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following this transaction, Mr. Heyburn beneficially owns 1,548,997 shares of Class A common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While it involves a transaction by a key executive, the sale is attributed to tax obligations, which is a routine event and not necessarily indicative of negative sentiment towards the company's prospects.

Negatives

• Insider selling of company stock can sometimes be perceived negatively by the market, although in this case, the sale was to cover tax obligations.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While this filing details a disposition of shares by a key executive, the reason cited (tax withholding) is a common and often non-indicative event for future stock performance.

Stakeholder Impact

• Shareholders: The transaction itself is unlikely to have a significant direct impact on shareholders, as it is a standard tax-related event. However, any perception of insider selling can influence market sentiment.
• Employees: The transaction relates to restricted stock units vesting for an executive, which is part of standard executive compensation practices.
• Management: The filing confirms the ongoing roles of William A. Heyburn as Director, Co-CEO, and CFO.

Key Dates

Keywords

Strata Critical Medical, SRTA, Form 4, Insider Transaction, Stock Sale, William A. Heyburn, Co-CEO, CFO, Director, Tax Withholding